United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 11, 2026 · Filed Aug 12, 2026

On Aug 11, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$522.87 for US$4.97M under a trading plan, leaving 324,443 shares. Filed Aug 12, 2026 (Form 4).

Sold
9,500 shares
Price
US$522.87 average (US$513.37 to US$531.01)
Value
US$4.97M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 11, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 11, 2026Common StockSale475US$513.37333,468Indirect
Aug 11, 2026Common StockSale1,214US$514.52332,254Indirect
Aug 11, 2026Common StockSale360US$515.52331,894Indirect
Aug 11, 2026Common StockSale520US$516.91331,374Indirect
Aug 11, 2026Common StockSale120US$517.57331,254Indirect
Aug 11, 2026Common StockSale120US$518.95331,134Indirect
Aug 11, 2026Common StockSale200US$520.59330,934Indirect
Aug 11, 2026Common StockSale200US$521.73330,734Indirect
Aug 11, 2026Common StockSale221US$523.04330,513Indirect
Aug 11, 2026Common StockSale379US$524.13330,134Indirect
Aug 11, 2026Common StockSale871US$525.19329,263Indirect
Aug 11, 2026Common StockSale2,725US$526.05326,538Indirect
Aug 11, 2026Common StockSale935US$527.16325,603Indirect
Aug 11, 2026Common StockSale737US$528.07324,866Indirect
Aug 11, 2026Common StockSale143US$529.05324,723Indirect
Aug 11, 2026Common StockSale280US$531.01324,443Indirect

Source

View original at SEC

Related